What's new

Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 11, Status: Authorised

Jun 10, 2025 - 16:25
 0
Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 11, Status: Authorised
Read More

Tags:

Previous Article

EMEA-003439-PIP02-23

Next Article

Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, ...

Related Posts

EVVET – Data warehouse user manual

May 16, 2025  0

EMEA-003063-PIP03-22

EMEA-003063-PIP03-22

May 26, 2025  0

Human medicines European public assessment report (EPAR): Skyrizi, risankizumab, Date of authorisation: 26/04/2019, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 11, 2025  0